Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism

Radiology

Volumn 253, Issue 1, 2009, Pages 216-222

  Capito, Carmen ^a   Khen Dunlop, Naziha ^a   Ribeiro, Maria João ^b   Brunelle, Francis ^a   Aigrain, Yves ^a   Crétolle, Célia ^a   Jaubert, Francis ^a   De Lonlay, Pascale ^a   Nihoul Fékété, Claire ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b DIF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

6 FLUORODOPA F 18; C PEPTIDE; GLUCOSE; INSULIN; DIAGNOSTIC AGENT; DOPA; DRUG DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INTERMETHOD COMPARISON; MALE; PANCREAS; PANCREAS DISEASE; PANCREAS RESECTION; PANCREAS VENOUS SAMPLING; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; VENOUS BLOOD; COMPUTER ASSISTED DIAGNOSIS; INFANT; METHODOLOGY; NEWBORN; NONPARAMETRIC TEST; RECURRENT DISEASE; RETROSPECTIVE STUDY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

DIAGNOSTIC ERRORS; DIHYDROXYPHENYLALANINE; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INFANT; INFANT, NEWBORN; MALE; PERSISTENT HYPERINSULINEMIA HYPOGLYCEMIA OF INFANCY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECURRENCE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 70350516676     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2532081445     Document Type: Article

References (22)

1. De León DD, Stanley CA. Mechanisms of disease: advances in diagnosis and treatment of hyperinsulinism in neonates. Nat Clin Pract Endocrinol Metab 2007;3(1):57-68.
2. Menni F, de Lonlay P, Sevin C, et al. Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia. Pediatrics 2001;107(3):476-479.
3. Goossens A, Gepts W, Saudubray JM, et al. Diffuse and focal nesidioblastosis: a clinicopathological study of 24 patients with persistent neonatal hyperinsulinemic hypoglycemia. Am J Surg Pathol 1989;13(9):766-775.
4. Sempoux C, Guiot Y, Jaubert F, Rahier J. Focal and diffuse forms of congenital hyperinsulinism: the keys for differential diagnosis. Endocr Pathol 2004;15(3):241-246.
5. Fékété CN, de Lonlay P, Jaubert F, Rahier J, Brunelle F, Saudubray JM. The surgical management of congenital hyperinsulinemic hypoglycemia in infancy. J Pediatr Surg 2004;39(3):267-269.
6. Cherian MP, Abduljabbar MA. Persistent hyperinsulinemic hypoglycemia of infancy (PHHI): long-term outcome following 95% pancreatectomy. J Pediatr Endocrinol Metab 2005;18(12):1441-1448.
7. Giurgea I, Bellanné-Chantelot C, Ribeiro M, et al. Molecular mechanisms of neonatal hyperinsulinism. Horm Res 2006;66(6):289-296.
8. Sempoux C, Guiot Y, Dahan K, et al. The focal form of persistent hyperinsulinemic hypoglycemia of infancy: morphological and molecular studies show structural and functional differences with insulinoma. Diabetes 2003;52(3):784-794.
9. Adzick NS, Thornton PS, Stanley CA, Kaye RD, Ruchelli E. A multidisciplinary approach to the focal form of congenital hyperinsulinism leads to successful treatment by partial pancreatectomy. J Pediatr Surg 2004;39(3):270-275.
10. Crétolle C, de Lonlay P, Sauvat F, et al. Congenital hyperinsulinism of infancy: surgical treatment in 60 cases of focal form [in French]. Arch Pediatr 2005;12(3):258-263.
11. Dubois J, Brunelle F, Touati G, et al. Hyperinsulinism in children: diagnostic value of pancreatic venous sampling correlated with clinical, pathological and surgical outcome in 25 cases. Pediatr Radiol 1995;25(7):512-516.
12. Brunelle F, Negre V, Barth MO, et al. Pancreatic venous samplings in infants and children with primary hyperinsulinism. Pediatr Radiol 1989;19(2):100-103.
13. Ahlström H, Eriksson B, Bergström M, Bjurling P, Långström B, Oberg K. Pancreatic neuroendocrine tumors: diagnosis with PET. Radiology 1995;195(2):333-337.
14. Hardy OT, Hernandez-Pampaloni M, Saffer JR, et al. Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan. J Pediatr 2007;150(2):140-145.
15. Ribeiro MJ, De Lonlay P, Delzescaux T, et al. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA. J Nucl Med 2005;46(4):560-566.
16. Von Schulthess GK, Hany TF. Imaging and PET-PET/CT imaging. J Radiol 2008;89(3 pt 2):438-447.
17. Mohnike K, Blankenstein O, Minn H, Mohnike W, Fuchtner F, Otonkoski T. [18F]-DOPA positron emission tomography for preoperative localization in congenital hyperinsulinism. Horm Res 2008;70(2):65-72.
18. Mohnike K, Blankenstein O, Christesen HT, et al. Proposal for a standardized protocol for 18F-DOPA-PET (PET/CT) in congenital hyperinsulinism. Horm Res 2006;66(1):40-42.
19. Blodgett TM, Meltzer CC, Townsend DW. PET/CT: form and function. Radiology 2007;242(2):360-385.
20. von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: current applications and future directions. Radiology 2006;238(2):405-422.
21. Barthlen W, Blankenstein O, Mau H, et al. Evaluation of [18F]Fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism. J Clin Endocrinol Metab 2008;93(3):869-875.
22. Subramaniam RM, Karantanis D, Peller PJ. [18F]Fluoro-L-dopa PET/CT in congenital hyperinsulinism. J Comput Assist Tomogr 2007;31(5):770-772.